EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Caffeine Acts as an Agonist of Siglec‐6, Inhibits MRGPRX2‐Triggered Mast Cell Degranulation and Anaphylactoid Reactions

Yuanyuan Ding, Na Wang, Chenrui Zhao, Hongfen Du, Yujuan Yuan, Tao Zhang, Hongli An iD

Mediators of Inflammation · 2025

DOI: 10.1155/mi/9580121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, 2025. Verfasst von Yuanyuan Ding und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China. Hauptthemen laut MEDLINE: Mast Cells, Receptors, G-Protein-Coupled, Anaphylaxis, Caffeine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mast cells (MCs) are effectors of anaphylactoid reactions. Mas‐related G‐protein‐coupled receptor X2 (MRGPRX2) receptor mediates the direct activation of MCs in anaphylactoid disease. Siglec‐6 negatively regulates MC activation and is a promising target in the development of antianaphylactoid reaction drugs. While caffeine exhibits an inhibitory effect against anaphylactic shock, the molecular mechanisms underlying these activities remain unknown.

Objectives

Our objective was to investigate the inhibitory effect of caffeine and its underlying molecular mechanism in MRPGRX2‐induced MC activation and anaphylactoid reactions.

Methods

Local and systemic anaphylactoid reactions in mice and in vitro MC activation experiments were conducted to investigate the effects of caffeine on anaphylactoid reactions. Molecular docking and surface plasmon resonance (SPR) experiments were used to predict and verify the molecular target of caffeine activity. siRNA silencing and western blot analyses were utilized to investigate the molecular mechanisms underlying caffeine activity.

Results

Caffeine inhibited local and systemic anaphylactoid reactions in mice and attenuated MRGPRX2‐induced MC activation. Release of β‐hexosaminidase, histamine, and Ca 2+ in siRNA‐Siglec‐6‐laboratory allergic disease 2 (LAD2) cells was significantly higher than in NC‐LAD2 cells. The binding affinity between caffeine and Siglec‐6 protein is with a calculated K D of 1.76 × 10 −7 mol/L. Caffeine increased Siglec‐6 expression, phosphorylation of SHP‐1, and dephosphorylation of PLC‐γ1, IP3R, and ERK1/2 in the MRGPRX2 signaling pathway. Western blot demonstrated that phosphorylated SHP‐1 (p‐SHP‐1) protein levels showed no increase, and MRGPRX2, phosphorylated PLCγ1 (p‐PLCγ1), and phosphorylated ERK1/2 (p‐ERK1/2) were abolished with caffeine treatment in Siglec‐6‐knockdown cells than in NC‐knockdown cells. Caffeine suppressed the m‐3M3FBS‐induced upregulation of p‐PLCγ1 and p‐ERK1/2 levels.

Conclusions

We have demonstrated that caffeine is an agonist of Siglec‐6 and that subsequent activation of the ITIM motif of Siglec‐6 phosphorylates SHP‐1. This arrests MRGPRX2/PLC‐γ1/IP3R signal transduction, thereby attenuating anaphylactoid reactions, including anaphylactic shock.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mast CellsReceptors, G-Protein-CoupledAnaphylaxisCaffeineReceptors, NeuropeptideCell DegranulationAnimalsMiceMolecular Docking SimulationMaleMice, Inbred BALB C

Stichwörter der Autor:innen

MRGPRX2Siglec-6anaphylactoid reactioncaffeinemast cell degranulation

Substanzen

Receptors, G-Protein-CoupledCaffeineMrgprx2 protein, mouseReceptors, Neuropeptide

Autor:innen und Institutionen

  • Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
  • College of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, Shaanxi, China.
  • Department of Otolaryngology, Affiliated Hospital of North China University of Science and Technology, Tangshan 063000, China.
  • Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi, China.

ORCID-Profile: Hongli An

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Ding, Y., Wang, N., Zhao, C., Du, H., Yuan, Y., Zhang, T., & An, H. (2025). Caffeine Acts as an Agonist of Siglec‐6, Inhibits MRGPRX2‐Triggered Mast Cell Degranulation and Anaphylactoid Reactions. Mediators of Inflammation. https://doi.org/10.1155/mi/9580121

Vancouver

Ding Y, Wang N, Zhao C, Du H, Yuan Y, Zhang T, et al. Caffeine Acts as an Agonist of Siglec‐6, Inhibits MRGPRX2‐Triggered Mast Cell Degranulation and Anaphylactoid Reactions. Mediators of Inflammation. 2025. doi:10.1155/mi/9580121

BibTeX
@article{Ding2025,
  author = {Ding, Yuanyuan and Wang, Na and Zhao, Chenrui and Du, Hongfen and Yuan, Yujuan and Zhang, Tao and An, Hongli},
  title = {Caffeine Acts as an Agonist of Siglec‐6, Inhibits MRGPRX2‐Triggered Mast Cell Degranulation and Anaphylactoid Reactions},
  journal = {Mediators of Inflammation},
  year = {2025},
  doi = {10.1155/mi/9580121}
}
Kostenlos starten →